Tabetha Hale Bradley, MD | |
503 E Highland Ave, Chelan, WA 98816-8631 | |
(509) 682-8517 | |
(509) 682-9614 |
Full Name | Tabetha Hale Bradley |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 503 E Highland Ave, Chelan, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861695512 | NPI | - | NPPES |
1020730 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD60274491 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tabetha Hale Bradley, MD 503 E Highland Ave, Chelan, WA 98816-8631 Ph: (509) 682-8517 | Tabetha Hale Bradley, MD 503 E Highland Ave, Chelan, WA 98816-8631 Ph: (509) 682-8517 |
News Archive
The Loyola Center for Metabolic Surgery & Bariatric Care is designated a Level 1 facility under the Bariatric Surgery Center Network (BSCN) Accreditation Program of the American College of Surgeons (ACS).
Primex Wireless – the leading provider of solutions to automate and maintain facility compliance, increase efficiencies and reduce risk for enterprise organizations – announced the release of its latest SNS Applications Management Platform (AMP 4.0) software, incorporating support for the company's new SNS Differential Pressure Monitoring solution.
The University of Oklahoma Water Technologies for Emerging Regions (WaTER) Center has named development activist Ada Oko-Williams as the recipient of the 2013 University of Oklahoma International Water Prize. Oko-Williams, associate director at Water and Sanitation for Africa, was nominated and selected for her advocacy and collaborative community approach for clean water, sanitation and hygiene in Africa.
"The Transcendental Meditation Program, a widely-used standardized program to reduce stress, showed significant decreases in blood pressure and improved mental health in young adults at risk for hypertension," said David Haaga, PhD, co-author of the study and professor of psychology at American University in Washington, D.C.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
› Verified 8 days ago
Brandon Gene Douglass, Surgery Medicare: Medicare Enrolled Practice Location: 110 S Apple Blossom Dr, Chelan, WA 98816 Phone: 509-682-3300 |